Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells

Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells

US Patent 11408005 · Granted Aug 9, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Truncated epiderimal growth factor receptor (EGFRt) for transduced t cell select2025
Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labe2025
Methods of use for CAR T cells2025
Production of engineered T-cells by sleeping beauty transposon coupled with meth2025
Sequencing method for CAR T cell therapy2025
Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD192025
Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD192025
Drug regulated transgene expression2025
Closed-system manufacturing process for CAR-T cells2024
Methods and compositions comprising B7H3 chimeric antigen receptors2024
Nucleic acids encoding IL-13 receptor alpha 2 (IL13Ra2) chimeric antigen recepto2024
Early intervention methods to prevent or ameliorate toxicity2024